慢性疼痛治療の世界市場レポート 2025年

慢性疼痛治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.2%で、1,550億米ドルに成長します。予測期間の成長は、非オピオイド代替薬へのシフト、疼痛研究に対する政府資金の増加、個別化医療に対する需要の高まり、デジタル疼痛管理ツールの採用拡大、疼痛診断と治療計画におけるAIの利用拡大などに起因すると考えられます。この期間の主要動向には、神経調節療法の進歩、遠隔医療と疼痛治療の統合、カンナビノイドベースの治療開発、集学的治療アプローチの重視、ウェアラブル疼痛モニタリングデバイスの台頭などがあります。

関節炎性疼痛の有病率の上昇は、今後数年間の慢性疼痛治療市場の成長を大きく牽引すると予想されます。関節炎の痛みは、炎症や変性による関節の不快感、痛み、シビレを特徴とし、世界人口の高齢化に伴ってますます一般的になっています。時間の経過に伴う関節の自然な磨耗や損傷は、関節炎関連疾患の高い発生率につながり、それによって効果的な慢性疼痛管理の需要が増加しています。炎症と神経過敏を対象にした治療は、痛みを軽減し、関節機能を改善し、持続的な関節炎の症状に苦しむ人々の生活の質を高めるのに役立ちます。例えば、2023年3月、英国政府機関であるOffice for Health Improvement and Disparitiesは、2022年には16歳以上の17.6%が関節炎や慢性関節障害などの長期的な筋骨格系疾患を有しており、2021年の17.0%から増加していると報告しています。その結果、この有病率の増加が慢性疼痛治療市場を前進させる重要な要因となっています。

慢性疼痛治療市場で事業を展開する主要企業は、患者の利便性を向上させ、長期的な疼痛管理の成果を高めるため、充電式脊髄刺激装置のような革新的な製品の開発に注力しています。充電式脊髄刺激装置は背骨の近くに設置する植え込み型医療機器で、電気パルスを供給して痛みの信号を遮断します。この技術は、脊髄の疼痛経路を遮断することで慢性疼痛を管理し、背部手術失敗症候群や神経障害性疼痛などに苦しむ患者の疼痛知覚を軽減します。例えば、米国の医療機器メーカーであるアボット・ラボラトリーズは2022年12月、脊髄刺激システム「エテルナ」を発売しました。コンパクトで目立たない、AppleのAirPodsケースよりも小さいこの装置は、大幅な痛みの緩和を提供し、オピオイド依存を軽減する可能性が示されており、低侵襲で長期使用できるように設計されており、最終的には患者の日常機能と生活の質を向上させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の慢性疼痛治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の慢性疼痛治療市場：成長率分析
• 世界の慢性疼痛治療市場の実績：規模と成長、2019～2024年
• 世界の慢性疼痛治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の慢性疼痛治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の慢性疼痛治療市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤
• デバイス
• 世界の慢性疼痛治療市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 神経障害性疼痛
• 関節炎の痛み
• 慢性的な腰痛
• がんの痛み
• 片頭痛
• 線維筋痛症
• その他
• 世界の慢性疼痛治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 直接
• 間接
• 世界の慢性疼痛治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 介護施設
• 研究センターと大学
• その他
• 世界の慢性疼痛治療市場、薬剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• 抗うつ薬
• 抗けいれん薬
• 筋弛緩剤
• 局所鎮痛剤
• その他の鎮痛薬
• 世界の慢性疼痛治療市場、デバイスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 神経調節デバイス
• 経皮的電気神経刺激（TENS）装置
• 脊髄刺激装置
• 末梢神経刺激装置
• 高周波アブレーション装置
• 埋め込み型ドラッグデリバリーデバイス

第7章 地域別・国別分析

• 世界の慢性疼痛治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の慢性疼痛治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性疼痛治療市場：競合情勢
• 慢性疼痛治療市場：企業プロファイル
  • Pfizer Inc.
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • Sanofi S.A.

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals LLC
• Mallinckrodt plc
• Nevro Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 慢性疼痛治療市場、2029年：新たな機会を提供する国
• 慢性疼痛治療市場、2029年：新たな機会を提供するセグメント
• 慢性疼痛治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Chronic pain treatment involves ongoing management of pain lasting longer than three months, often extending beyond normal healing time. It typically combines medications, physical therapy, psychological support, and lifestyle modifications to reduce pain severity, improve functional abilities, and enhance overall quality of life.

The primary product types in chronic pain treatment include drugs and devices. Drugs for chronic pain work by targeting inflammation, nerve signaling, or underlying causes to alleviate persistent pain and improve patient outcomes. These medications address a variety of conditions such as neuropathic pain, arthritis, chronic back pain, cancer-related pain, migraine, fibromyalgia, and more. They are distributed through multiple channels, including both direct and indirect methods, and are utilized by a diverse set of end users including hospitals, clinics, nursing homes, research institutions, and universities.

The chronic pain treatment market research report is one of a series of new reports from The Business Research Company that provides chronic pain treatment market statistics, including the chronic pain treatment industry global market size, regional shares, competitors with the chronic pain treatment market share, detailed chronic pain treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pain treatment industry. These chronic pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic pain treatment market size has grown strongly in recent years. It will grow from $99.64 billion in 2024 to $109.05 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to the aging population, increasing prevalence of chronic diseases, heightened awareness of pain management, growth in prescription opioid use, and expansion of health insurance coverage.

The chronic pain treatment market size is expected to see strong growth in the next few years. It will grow to $155.00 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to a shift toward non-opioid alternatives, increased government funding for pain research, rising demand for personalized medicine, growing adoption of digital pain management tools, and expanding use of AI in pain diagnosis and treatment planning. Major trends during this period include advancements in neuromodulation therapies, integration of telemedicine into pain care, development of cannabinoid-based treatments, emphasis on multidisciplinary treatment approaches, and the rise of wearable pain monitoring devices.

The rising prevalence of arthritis pain is expected to significantly drive the growth of the chronic pain treatment market in the coming years. Arthritis pain, characterized by discomfort, aching, or soreness in the joints due to inflammation or degeneration, is increasingly common as the global population ages. The natural wear and tear on joints over time leads to a higher incidence of arthritis-related conditions, thereby increasing the demand for effective chronic pain management. Treatments targeting inflammation and nerve sensitivity help reduce pain, improve joint function, and enhance the quality of life for those suffering from persistent arthritis symptoms. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that 17.6% of individuals aged 16 and older had a long-term musculoskeletal condition, such as arthritis or chronic joint problems, in 2022-an increase from 17.0% in 2021. Consequently, this growing prevalence is a key factor propelling the chronic pain treatment market forward.

Major companies operating in the chronic pain treatment market are focusing on developing innovative products like rechargeable spinal cord stimulators to improve patient convenience and enhance long-term pain management outcomes. A rechargeable spinal cord stimulator is an implantable medical device placed near the spine that delivers electrical pulses to disrupt pain signals, with the added benefit of being externally rechargeable, eliminating the need for additional surgeries. This technology helps manage chronic pain by blocking pain pathways in the spinal cord, thus reducing pain perception in patients suffering from conditions such as failed back surgery syndrome and neuropathic pain. For example, in December 2022, Abbott Laboratories, a US-based medical device company, launched the Eterna spinal cord stimulation system. Compact and discreet-smaller than an Apple AirPods case-this device offers significant pain relief, has shown potential in reducing opioid dependence, and is designed for minimally invasive, long-term use, ultimately improving patients' daily functioning and quality of life.

In May 2025, electroCore Inc., a US-based bioelectronic technology company, acquired NeuroMetrix Inc. for an undisclosed amount. Through this acquisition, electroCore aims to bolster its leadership in the non-invasive bioelectronic therapy market by integrating NeuroMetrix's Quell platform, thereby expanding its product portfolio and accelerating growth in the chronic pain and wellness sectors-especially within the Veterans Affairs (VA) Hospital System. NeuroMetrix Inc., based in the US, specializes in developing non-invasive therapeutic devices targeting chronic pain conditions like fibromyalgia.

Major players in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, and Nevro Corp.

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic pain treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pain treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy, psychological counseling, interventional pain management, alternative therapies, pain management clinics, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain treatment market also includes sales of lyrica, cymbalta, oxycontin, neurontin, voltaren gel, quell, and precision spectra spinal cord stimulator. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Drugs; Devices
• 2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
• 3) By Distribution channels: Direct; Indirect
• 4) By End-User: Hospitals; Clinics; Nursing Homes; Research Centers And Universities; Other End-Users
• Subsegments:
• 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Antidepressants; Anticonvulsants; Muscle Relaxants; Topical Analgesics; Other Pain Relief Medications
• 2) By Devices: Neuromodulation Devices; Transcutaneous Electrical Nerve Stimulation (TENS) Devices; Spinal Cord Stimulators; Peripheral Nerve Stimulators; Radiofrequency Ablation Devices; Implantable Drug Delivery Devices
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Pain Treatment Market Characteristics

3. Chronic Pain Treatment Market Trends And Strategies

4. Chronic Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Chronic Pain Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Pain Treatment Market Growth Rate Analysis
• 5.4. Global Chronic Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Pain Treatment Total Addressable Market (TAM)

6. Chronic Pain Treatment Market Segmentation

• 6.1. Global Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Devices
• 6.2. Global Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Arthritis Pain
• Chronic Back Pain
• Cancer Pain
• Migraine
• Fibromyalgia
• Other Indications
• 6.3. Global Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct
• Indirect
• 6.4. Global Chronic Pain Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Nursing Homes
• Research Centers And Universities
• Other End-Users
• 6.5. Global Chronic Pain Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Opioids
• Antidepressants
• Anticonvulsants
• Muscle Relaxants
• Topical Analgesics
• Other Pain Relief Medications
• 6.6. Global Chronic Pain Treatment Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuromodulation Devices
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices
• Spinal Cord Stimulators
• Peripheral Nerve Stimulators
• Radiofrequency Ablation Devices
• Implantable Drug Delivery Devices

7. Chronic Pain Treatment Market Regional And Country Analysis

• 7.1. Global Chronic Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Pain Treatment Market

• 8.1. Asia-Pacific Chronic Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Pain Treatment Market

• 9.1. China Chronic Pain Treatment Market Overview
• 9.2. China Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Pain Treatment Market

• 10.1. India Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Pain Treatment Market

• 11.1. Japan Chronic Pain Treatment Market Overview
• 11.2. Japan Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Pain Treatment Market

• 12.1. Australia Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Pain Treatment Market

• 13.1. Indonesia Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Pain Treatment Market

• 14.1. South Korea Chronic Pain Treatment Market Overview
• 14.2. South Korea Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Pain Treatment Market

• 15.1. Western Europe Chronic Pain Treatment Market Overview
• 15.2. Western Europe Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Pain Treatment Market

• 16.1. UK Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Pain Treatment Market

• 17.1. Germany Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Pain Treatment Market

• 18.1. France Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Pain Treatment Market

• 19.1. Italy Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Pain Treatment Market

• 20.1. Spain Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Pain Treatment Market

• 21.1. Eastern Europe Chronic Pain Treatment Market Overview
• 21.2. Eastern Europe Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Pain Treatment Market

• 22.1. Russia Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Pain Treatment Market

• 23.1. North America Chronic Pain Treatment Market Overview
• 23.2. North America Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Pain Treatment Market

• 24.1. USA Chronic Pain Treatment Market Overview
• 24.2. USA Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Pain Treatment Market

• 25.1. Canada Chronic Pain Treatment Market Overview
• 25.2. Canada Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Pain Treatment Market

• 26.1. South America Chronic Pain Treatment Market Overview
• 26.2. South America Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Pain Treatment Market

• 27.1. Brazil Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Pain Treatment Market

• 28.1. Middle East Chronic Pain Treatment Market Overview
• 28.2. Middle East Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Pain Treatment Market

• 29.1. Africa Chronic Pain Treatment Market Overview
• 29.2. Africa Chronic Pain Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Pain Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Pain Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Pain Treatment Market Competitive Landscape And Company Profiles

• 30.1. Chronic Pain Treatment Market Competitive Landscape
• 30.2. Chronic Pain Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Pain Treatment Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. Novartis AG
• 31.5. GlaxoSmithKline plc
• 31.6. Medtronic plc
• 31.7. Eli Lilly and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Boston Scientific Corporation
• 31.11. Bausch Health Companies Inc.
• 31.12. Sun Pharmaceutical Industries Ltd.
• 31.13. Amneal Pharmaceuticals LLC
• 31.14. Mallinckrodt plc
• 31.15. Nevro Corp.

32. Global Chronic Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Pain Treatment Market

34. Recent Developments In The Chronic Pain Treatment Market

35. Chronic Pain Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Pain Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Pain Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Pain Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer